
Eva Feldman, M.D., Ph.D.
Russell N. DeJong Professor of Neurology
Professor, Neurology
Director, ALS Center of Excellence
Director, NeuroNetwork for Emerging Therapies
One of the advantages of stem cells without immunogenicity is we can mass-produce them and make them inexpensive-Dr. Eva Feldman